Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02890368
Title Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Trillium Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Oregon Health & Science University Portland Oregon 97239 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15237 United States Details
Inova Schar Cancer Institute Fairfax Virginia 22031 United States Details
University of Washington - Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field